BackSynbio Tech Overview

Synbio Tech Accounts Payable

Latest accounts payable for 1295.TWO: $37M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$37.30M
↓ 45.01% YoYΔ $-30.53M vs prior year quarter

Peer trimmed avg / median

Loading

Synbio Tech Accounts Payable History

Loading

Synbio Tech vs. peers: Accounts Payable Comparison

Loading

Synbio Tech Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Synbio Tech (1295.TWO) FAQ

As of the most recent data (June 2026), 1295.TWO shows a accounts payable of $37M. That compares with $68M in the prior-year period — down 45.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1295.TWO's accounts payable is now $37M (was $68M) — a 45.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Synbio Tech is outperforming or lagging.

Tracking 1295.TWO's accounts payable over time shows whether Synbio Tech is scaling, shrinking, or reshaping that part of the business. The current reading is $37M That compares with $68M in the prior-year period — down 45.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Synbio Tech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $37M) with ownership activity and broader fundamentals.

Synbio Tech's accounts payable is $37M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.